DE3787002D1 - Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen. - Google Patents

Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.

Info

Publication number
DE3787002D1
DE3787002D1 DE8787311391T DE3787002T DE3787002D1 DE 3787002 D1 DE3787002 D1 DE 3787002D1 DE 8787311391 T DE8787311391 T DE 8787311391T DE 3787002 T DE3787002 T DE 3787002T DE 3787002 D1 DE3787002 D1 DE 3787002D1
Authority
DE
Germany
Prior art keywords
proteins
synthetic peptides
immunity against
cellular immunity
aids virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787311391T
Other languages
English (en)
Other versions
DE3787002T2 (de
Inventor
Jay A Berzofsky
Kemp B Cease
Charles Delisi
Hanah Margalit
James L Cornette
Cecilia Spencer Ouyang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE3787002D1 publication Critical patent/DE3787002D1/de
Publication of DE3787002T2 publication Critical patent/DE3787002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE87311391T 1986-12-30 1987-12-23 Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen. Expired - Lifetime DE3787002T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94793586A 1986-12-30 1986-12-30
US1443087A 1987-02-12 1987-02-12

Publications (2)

Publication Number Publication Date
DE3787002D1 true DE3787002D1 (de) 1993-09-16
DE3787002T2 DE3787002T2 (de) 1993-11-25

Family

ID=26686083

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87311391T Expired - Lifetime DE3787002T2 (de) 1986-12-30 1987-12-23 Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen.

Country Status (7)

Country Link
EP (1) EP0273716B1 (de)
JP (1) JPH0762031B2 (de)
AU (1) AU592258B2 (de)
CA (1) CA1340896C (de)
DE (1) DE3787002T2 (de)
IL (1) IL84980A (de)
WO (1) WO1988005051A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5939074A (en) * 1986-12-30 1999-08-17 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptide antigens
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
EP0279688B1 (de) * 1987-02-20 1997-04-16 Genentech, Inc. Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
AU2914889A (en) * 1987-08-28 1989-04-17 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
EP0400076B1 (de) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetisches antigen zum bewirken einer anti-hiv-reaktion
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5185147A (en) * 1988-08-19 1993-02-09 Cellular Products, Inc. Short polypeptide sequences useful in the production and detection of antibodies against human immunodeficiency virus
EP0362909A3 (de) * 1988-08-26 1990-11-14 Akzo N.V. Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
FR2640877A1 (de) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
CA2025634A1 (en) * 1989-09-19 1991-03-20 Thomas Fuerst Peptides including ctl epitopes of hiv proteins and use thereof
EP0493508A1 (de) * 1989-09-22 1992-07-08 Idec Pharmaceuticals Corporation Von der cd4-bindungsregion des gp120 abgeleitete neue peptide und die art ihrer verwendung
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
AU662534B2 (en) * 1991-06-03 1995-09-07 Syntello Vaccine Development Ab Peptides for use in induction of T cell activation against HIV-1
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
ES2257733T3 (es) * 1991-08-29 2006-08-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Antigenos peptidicos multideterminantes que estimulan la respuesta de los linfocitos auxiliares al hiv en una amplia gama de humanos.
WO1993015750A1 (en) * 1992-02-10 1993-08-19 Haynes Barton F Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
US5607914A (en) * 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
AU715731B2 (en) * 1994-10-20 2000-02-10 Institut Pasteur Nucleotide sequences of HIV-1 group (or subtype) O retrovirus antigens
US5714577A (en) * 1996-01-26 1998-02-03 University Of Pittsburgh Antimicrobial peptides
WO2000076537A2 (en) * 1997-09-10 2000-12-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
US6749856B1 (en) 1997-09-11 2004-06-15 The United States Of America, As Represented By The Department Of Health And Human Services Mucosal cytotoxic T lymphocyte responses
CN1230444C (zh) 1998-11-16 2005-12-07 德克萨斯州立大学董事会 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
WO2000058438A2 (en) * 1999-03-29 2000-10-05 David Bernstein Conformationally constrained peptides
IL150961A0 (en) * 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
JP4419549B2 (ja) 2003-07-18 2010-02-24 東レ株式会社 極細短繊維不織布および皮革様シート状物ならびにそれらの製造方法
JP2008535783A (ja) 2005-02-15 2008-09-04 サイモン・エル・エル・シー Ｈｉｖ−１の増殖を弱めるための方法および組成物
WO2009012143A2 (en) 2007-07-13 2009-01-22 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Virus derived antimicrobial peptides
US9399663B2 (en) * 2014-02-24 2016-07-26 Georgetown University Competitive inhibitor of GP120
WO2021092382A1 (en) 2019-11-08 2021-05-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions comprising antimicrobial peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
ATE71150T1 (de) * 1984-09-19 1992-01-15 Univ California Retrovirale polypeptide in zusammenhang mit menschlicher transformation.
PT81338B (pt) * 1984-10-18 1987-11-11 Pasteur Institut Antigenios, em especial antigenios do envolucro do virus de linfoadenopatias e do sindroma de imuno-deficiencia adquirido, e virus, processo para a producao de antigenios do envolucro do virus, utilizacao destes antigenios na preparacao de composicoes imunogenicas ou no diagnostico da presenca de anticorpos contra este virus
NZ213823A (en) * 1984-10-26 1988-05-30 Us Health Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
DE3787002T2 (de) 1993-11-25
EP0273716A2 (de) 1988-07-06
CA1340896C (en) 2000-02-15
AU592258B2 (en) 1990-01-04
IL84980A0 (en) 1988-06-30
JPS63503227A (ja) 1988-11-24
WO1988005051A1 (en) 1988-07-14
JPH0762031B2 (ja) 1995-07-05
EP0273716B1 (de) 1993-08-11
EP0273716A3 (en) 1989-12-20
AU1365788A (en) 1988-07-27
IL84980A (en) 1993-06-10

Similar Documents

Publication Publication Date Title
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
NL192275B (nl) Eiwit van het AIDS-virus.
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
NL300249I1 (nl) Cefalosporinen en homologen, bereidingen en farmaceutische preparaten.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
DE69020039D1 (de) Azlakton-Pfropfcopolymere.
DK0538300T3 (da) O-Glycosyleret IFN-alfa
EP0269712A4 (de) An der pathogenese einer hiv-infektion beteiligte peptide.
DE69018647D1 (de) Arzneimittel.
FI915160A0 (fi) Polymermjukningsmedel foer polyvinylklorid.
DE69534778D1 (en) Cathepsin-02-protease
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
ZA9610721B (en) Grapevine leafroll virus proteins and their uses.
MX9201681A (es) 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas.
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
DE69206280D1 (de) Succinimid enthaltende Polymere und von diesen hergestellte Latices.
IT8819417A0 (it) Sussidio chirurgico ad azione osteotropa.
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
FI904357A0 (fi) Foerfarande foer aktivering av protein c.
ATE92934T1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
DE68906245D1 (de) Therapeutisches mittel gegen aids.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
MX9203757A (es) Derivado de eritromicina y la preparacion y uso del mismo.
FR2670116B1 (fr) Electrode, notamment electrode temporaire pour le cóoeur.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition